secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K/A
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001477932-25-008179
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx amends over-allotment terms; underwriter buys 1.19M shares and 1.73M warrants
--------------------------------------------------------------------------------

- Amendment permits separate exercise of over-allotment shares and warrants, not just combined.
- Underwriter exercised over-allotment: 1,194,000 shares at $0.51 and 1,732,500 warrants at $0.01.
- Net proceeds to VolitionRx of $582,426 after 7.0% underwriting discount and expenses.
- Underwriter also received warrants to buy 83,580 shares at $0.63, exercisable after 6 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225008179/0001477932-25-008179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225008179/vnrx_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-008179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer